Cerenome, Inc.'s next confirmed earnings release is scheduled for February 25, 2027.
| Earnings Date | 2/25/2027 |
As of June 30, 2026, Cerenome, Inc. has 7.31M shares outstanding.
| Shares Outstanding | 7.31M |
As of June 30, 2026, Cerenome, Inc. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.81, indicating moderate leverage, while an interest coverage ratio of -8.42 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.37 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.81 |
| Interest Coverage | -8.42 |
Over the twelve months ended June 30, 2026, Cerenome, Inc. posted a negative return on equity (ROE) of -614.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -214.01, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 26.25, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -614.05 |
| Return on Assets (ROA) | -214.01 |
| Employee Count | 26.25 |
These figures are as of the close on November 16, 2026.
| 50-Day Moving Average | 1.66 |
Over the twelve months ended June 30, 2026, Cerenome, Inc. generated - - in revenue and converted that into -26.09M in net income, yielding earnings per share of -4.46. EBITDA reached -25.94M, while operating income came in at -26.40M.
| Operating Income | -26.40M |
| Pretax Income | -26.09M |
| Net Income | -26.09M |
| EBITDA | -25.94M |
| EBIT | -26.40M |
| Earnings Per Share (EPS) | -4.46 |
As of June 30, 2026, Cerenome, Inc. holds 8.59M in cash and equivalents against 44,000.00 in total debt, resulting in a net debt position of -2.37M. Total book value stands at 5.46M, with working capital of 3.20M providing operational flexibility.
| Cash & Cash Equivalents | 8.59M |
| Total Debt | 44,000.00 |
| Net Debt | -2.37M |
| Equity (Book Value) | 5.46M |
| Book Value Per Share | 0.75 |
| Working Capital | 3.20M |
Cerenome, Inc. produced -22.17M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.37M in capital expenditures, free cash flow totaled -23.55M - equivalent to -4.03 per share.
| Operating Cash Flow | -22.17M |
| Capital Expenditures | -1.37M |
| Free Cash Flow | -23.55M |
| FCF Per Share | -4.03 |
Cerenome, Inc.'s most recent stock split took place on April 2, 2026 with a 25:1 split ratio.
| Last Split Date | 4/2/2026 |
| Split Ratio | 25:1 |